What changed recently
Newly published and updated guidelines across every system, newest first. Each entry links to the official source.
5 older updates are outside this window. Show all time
- Renal & GenitourinaryUS2026-05-072021 guideline with 2023 amendment → 2026Benign prostatic hyperplasia
The AUA replaced its 2021 BPH/LUTS guideline and the targeted 2023 amendment with a full rebuild published in 2026, based on a fresh systematic literature review. The document was restructured into three parts covering presentation and evaluation, medical management, and procedural or surgical management.
source ↗curation confidence 90% - Renal & GenitourinaryEU2026-01-012025 → 2026Urinary tract infection
The 2026 EAU urological infections guideline is a limited update of the 2025 edition adding 36 studies across two sections. It revises the diagnostic and antimicrobial treatment recommendations for cystitis, updates antibiotic dosages throughout, strengthens periprocedural antibiotic prophylaxis guidance for prostate biopsy, and adds a new section on the diagnosis and treatment of fungal urinary tract infections.
- Renal & GenitourinaryEU2026-01-012025 → 2026Nephrolithiasis
The 2026 EAU urolithiasis guideline is a full update of the 2025 edition incorporating 126 newly identified studies, with revised recommendations on renal colic management, medical expulsive therapy, antibiotic prophylaxis for shock wave lithotripsy, retrograde and antegrade ureteroscopy, percutaneous nephrolithotomy, management of antithrombotic therapy around stone treatment, and radiation protection in endourology.
- Renal & GenitourinaryEU2026-01-012025 → 2026Benign prostatic hyperplasia
The 2026 EAU male LUTS guideline is a full revision of the 2025 edition: it adds a new section on prostate cancer within the diagnostic chapter, changes the strength rating for beta-3 agonists in conservative treatment, expands the surgical chapter with two new subsections emphasising alternative enucleation and ablative techniques, and adds guidance on male urinary incontinence, detrusor underactivity and voiding dysfunction in younger men.
- Renal & GenitourinaryUS2025-11-202016 → 2025Nephrolithiasis
The AUA replaced its 2016 surgical stone guideline with a new edition released in November 2025, developed from a GRADE-based review of literature published between 2000 and 2025. It is issued as a three-part series spanning evaluation, treatment and future directions, and covers shock wave lithotripsy, ureteroscopy and both standard and mini percutaneous nephrolithotomy.
source ↗curation confidence 90% - Renal & GenitourinaryUS2025-09-042019 guideline (reviewed and reaffirmed 2022) → 2025 amendmentUrinary tract infection
The AUA, CUA and SUFU amended their 2019 recurrent uncomplicated UTI guideline in September 2025, after the document had been reviewed and its validity confirmed in 2022. The amended version carries 20 recommendations, with revisions concentrated in the evaluation section, including how the diagnosis of recurrent UTI is established and the strength assigned to patient-initiated self-start treatment.
source ↗curation confidence 90% - Renal & GenitourinaryGLOBAL2025-04-012021 (Chapter 4 of the KDIGO Glomerular Diseases guideline) → 2025Nephrotic syndrome
This guideline replaces Chapter 4 of the 2021 KDIGO glomerular diseases guideline, with most changes affecting treatment. It tightened the definition of infrequently relapsing disease from fewer than four to fewer than three relapses in a 12-month period and aligned its clinical definitions with the International Pediatric Nephrology Association guideline.
source ↗curation confidence 90%